Hints and tips:
Showing results for Janssen Pharmaceutica NV
...The deal between J&J's Janssen Pharmaceutica and the AU's African Vaccine Acquisition Trust can be expanded to an extra 180m doses in 2022....
FDA will now weigh whether to allow use of first single-dose jab to prevent the virus
...The deal will give J&J’s drugmaking division Janssen Pharmaceutica access to Momenta’s pipeline of products, including nipocalimab, a promising treatment for the rare muscular disease myasthenia gravis that...
...Pharmaceutica, Johnson & Johnson’s Belgian-based drugmaker....
GSK and MSD among 25 companies included in government’s £1bn ‘sector deal’
...A European distribution centre opened in 2012 by Janssen Pharmaceutica (part of the multinational Johnson & Johnson) met all of the criteria set by the regional government and received €11m out of a total...
...In part, it stemmed from the commitment of Paul Janssen, founder of Janssen Pharmaceutica, now part of J&J, whose sister died of TB. But it required the backing of the US parent group to keep going....
...A spokeswoman for the finance ministry, Geertje Janssen, said the ministry was studying the court’s decision and would decide shortly whether to appeal against it to the country’s Supreme Court....
...They are contained in a report published on Thursday, The future of healthcare in Africa, commissioned by Janssen Pharmaceutica, a Belgian subsidiary of Johnson & Johnson of the US....
...Janssen Pharmaceutica, a subsidiary of Johnson & Johnson, the US group, is in the process of setting up its second European distribution sector in Wallonia, having looked at competing sites in the Netherlands...
...Among other drugs companies, Novo Nordisk rose 3.2 per cent to DKr286.50; Basilea Pharmaceutica climbed 2.6 per cent to SFr87.65 and Merck gained 2.2 per cent to €63.74....
...Shares in Basilea Pharmaceutica jumped on Monday after the Swiss drugs maker’s eczema treatment Toctino was accepted for use in Scotland....
...The termination of a deal to co-promote Risperdal, an antipsychotic drug, with Janssen-Cilag, a UK pharmaceuticals division of Johnson & Johnson’s, provided a pre-tax boost of €149m ($194m) to the Organon...
International Edition